The role of metabolism in prostate cancer progression and bone metastases
<p>Prostate cancer (PCa) is the most common cancer in males in the Western world, and whilst treatment of localised disease is very effective, bone metastatic disease remains incurable and overall survival is only around 2-3 years. In view of this there is a need to identify novel therapeutics...
| Päätekijä: | |
|---|---|
| Muut tekijät: | |
| Aineistotyyppi: | Opinnäyte |
| Kieli: | English |
| Julkaistu: |
2019
|
| Aiheet: |